The AHF Global Public Health Institute for Latin America and the Caribbean, in collaboration with the National Institute of ...
Zimbabwe is among 10 nations rolling out lenacapavir, a twice-yearly HIV prevention shot. "We are excited to announce that ...
ViiV Healthcare, a healthcare company founded by Pfizer (NYSE:PFE) and GSK (NYSE:GSK), announced on Wednesday that its ...
South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool ...
6don MSNOpinion
The only thing standing between humanity and the end of HIV
A new drug called lenacapavir might entirely change the game, though.
KZN to receive Lenacapavir,new long-acting HIV prevention injection. Minister Motsoaledi confirms rollout to 360 clinics, for ...
The biopharma will aim to bolster its pipeline, with plans to present updated results for novel long-acting combination ...
One in 10 clinics in SA will start to hand out a twice-a-year anti-HIV jab as early as February. The country’s medicines ...
JOHANNESBURG - Lenacapavir is described as a gamechanger in the fight against HIV/Aids. The long-acting prevention injection only needs to be administered twice a year. The National AIDS Council and ...
The southern Africa nation recently met the UNAids 95-95-95 fast-track targets, meaning that 95% of those living with HIV ...
SANAC urges local production of HIV prevention drug Lenacapavir to boost South Africa’s health independence and fight the HIV ...
A newly approved HIV medication provides near-total protection against infection with just two injections a year. It's called Lenacapavir. But the high price of the drug could limit its reach. A newly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback